These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 22487785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
    Helmchen C, Sprenger A, Rambold H, Sander T, Kömpf D, Straumann D.
    Neurology; 2004 Aug 24; 63(4):752-3. PubMed ID: 15326263
    [No Abstract] [Full Text] [Related]

  • 7. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
    Kalla R, Glasauer S, Schautzer F, Lehnen N, Büttner U, Strupp M, Brandt T.
    Neurology; 2004 Apr 13; 62(7):1228-9. PubMed ID: 15079036
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical use of 4-aminopyridine in patients with downbeat nystagmus.
    Domínguez-Durán E, Mármol-Szombathy I, Baños-Roldán Ú, Sánchez-Gómez S.
    Acta Otorrinolaringol Esp (Engl Ed); 2020 Apr 13; 71(1):40-44. PubMed ID: 31078225
    [Abstract] [Full Text] [Related]

  • 11. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
    Bense S, Best C, Buchholz HG, Wiener V, Schreckenberger M, Bartenstein P, Dieterich M.
    Neuroreport; 2006 Apr 24; 17(6):599-603. PubMed ID: 16603919
    [Abstract] [Full Text] [Related]

  • 12. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
    Strupp M, Schüler O, Krafczyk S, Jahn K, Schautzer F, Büttner U, Brandt T.
    Neurology; 2003 Jul 22; 61(2):165-70. PubMed ID: 12874393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dalfampridine in patients with downbeat nystagmus--an observational study.
    Claassen J, Feil K, Bardins S, Teufel J, Spiegel R, Kalla R, Schneider E, Jahn K, Schniepp R, Strupp M.
    J Neurol; 2013 Aug 22; 260(8):1992-6. PubMed ID: 23589193
    [Abstract] [Full Text] [Related]

  • 15. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
    Kalla R, Teufel J, Feil K, Muth C, Strupp M.
    J Neurol; 2016 Apr 22; 263 Suppl 1():S24-9. PubMed ID: 27083881
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Medical treatment of acquired nystagmus.
    Ehrhardt D, Eggenberger E.
    Curr Opin Ophthalmol; 2012 Nov 22; 23(6):510-6. PubMed ID: 23014266
    [Abstract] [Full Text] [Related]

  • 20. 4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.
    Kremmyda O, Zwergal A, la Fougère C, Brandt T, Jahn K, Strupp M.
    J Neurol; 2013 Jan 22; 260(1):321-3. PubMed ID: 23180177
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.